Tosoh Bioscience, a leading name in the biotechnology sector, is headquartered in Great Britain and operates extensively across Europe, Asia, and North America. Founded in 2003, the company has established itself as a key player in the development and manufacturing of high-quality chromatography products and bioprocessing solutions.
With a focus on innovative technologies, Tosoh Bioscience offers a diverse range of core products, including affinity chromatography resins and analytical instruments, which are renowned for their reliability and performance. The company’s commitment to quality and customer satisfaction has solidified its market position, making it a trusted partner for laboratories and biopharmaceutical manufacturers worldwide. Notable achievements include significant advancements in protein purification and a robust portfolio that supports the evolving needs of the life sciences industry.
+3 vs industry average
Tosoh Bioscience’s score of 32 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Tosoh Bioscience?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Research Services has typical carbon intensity
Industry performance
The Research Services industry has increased its overall emissions by 17% since 2019
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Tosoh Bioscience's reported carbon emissions
In 2024, Tosoh Bioscience reported total greenhouse gas emissions of approximately 12.8 billion kg CO2e, comprising 7.3 billion kg CO2e from Scope 1, 468 million kg CO2e from Scope 2, and 5.8 billion kg CO2e from Scope 3 emissions. This reflects a slight decrease from 2023, where total emissions were about 12.9 billion kg CO2e, with Scope 1 emissions at 7.6 billion kg CO2e, Scope 2 at 467 million kg CO2e, and Scope 3 at 5.9 billion kg CO2e. Tosoh Bioscience has set ambitious climate commitments, aiming to reduce Scope 1 and Scope 2 greenhouse gas emissions by 30% by fiscal 2031 compared to fiscal 2019 levels. This long-term target underscores the company's commitment to sustainability and aligns with industry standards for climate action. The emissions data is not cascaded from any parent organization, indicating that Tosoh Bioscience Limited independently reports its emissions and climate initiatives. The company continues to focus on enhancing its environmental performance while addressing the challenges of climate change.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Tosoh Bioscience’s Climate Goals (2030 & 2050)
2 goals2031
30% reduction in Scope 2
Reduce Scope 1 + 2 GHG emissions by 30% in fiscal 2031 compared with fiscal 2019
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 2 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Tosoh Bioscience
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project